| Name | Carlumab |
|---|
| Description | Carlumab (CNTO 888) is a humanised anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
CCL2[1]. |
| References |
| No Any Chemical & Physical Properties |